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Abstract
Background: As many as 50% of people experience medication nonadherence, yet studies for detecting nonadherence and
delivering real-time interventions to improve adherence are lacking. Mobile health (mHealth) technologies show promise to track
and support medication adherence.
Objective: The study aimed to evaluate the feasibility and acceptability of using an mHealth system for medication adherence
tracking and intervention delivery. The mHealth system comprises a smart button device to self-track medication taking, a
companion smartphone app, a computer algorithm used to determine adherence and then deliver a standard or tailored SMS (short
message service) text message on the basis of timing of medication taking. Standard SMS text messages indicated that the
smartphone app registered the button press, whereas tailored SMS text messages encouraged habit formation and systems thinking
on the basis of the timing the medications were taken.
Methods: A convenience sample of 5 adults with chronic kidney disease (CKD), who were prescribed antihypertensive
medication, participated in a 52-day longitudinal study. The study was conducted in 3 phases, with a standard SMS text message
sent in phases 1 (study days 1-14) and 3 (study days 46-52) and tailored SMS text messages sent during phase 2 (study days
15-45) in response to participant medication self-tracking. Medication adherence was measured using: (1) the smart button and
(2) electronic medication monitoring caps. Concordance between these 2 methods was evaluated using percentage of measurements
made on the same day and occurring within ±5 min of one another. Acceptability was evaluated using qualitative feedback from
participants.
Results: A total of 5 patients with CKD, stages 1-4, were enrolled in the study, with the majority being men (60%), white (80%),
and Hispanic/Latino (40%) of middle age (52.6 years, SD 22.49; range 20-70). The mHealth system was successfully initiated
in the clinic setting for all enrolled participants. Of the expected 260 data points, 36.5% (n=95) were recorded with the smart
button and 76.2% (n=198) with electronic monitoring. Concordant events (n=94), in which events were recorded with both the
smart button and electronic monitoring, occurred 47% of the time and 58% of these events occurred within ±5 min of one another.
Participant comments suggested SMS text messages were encouraging.
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Conclusions: It was feasible to recruit participants in the clinic setting for an mHealth study, and our system was successfully
initiated for all enrolled participants. The smart button is an innovative way to self-report adherence data, including date and
timing of medication taking, which were not previously available from measures that rely on recall of adherence. Although the
selected smart button had poor concordance with electronic monitoring caps, participants were willing to use it to self-track
medication adherence, and they found the mHealth system acceptable to use in most cases.
(JMIR Form Res 2019;3(2):e13558)   doi:10.2196/13558
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Introduction
Background
An estimated 30% to 50% of people with chronic conditions
do not take medications as prescribed (eg, miss or skip doses,
take medications late, or not at all), known broadly as
medication nonadherence [1,2]. People who miss or skip taking
medications or take them late are at risk for stopping their
medications altogether [3]. Across all health conditions,
medication nonadherence contributes to prescription-related
morbidity and mortality, and nonadherence is estimated to cost
around US $528 billion annually [4]. Despite the potential to
improve patient outcomes associated with nonadherence,
developing effective interventions relies on measuring
medication adherence behaviors in a way that provides
actionable information for behavior change.
Medication adherence measurement methods vary widely and
include patient self-report (eg, questionnaires, interviews, and
diaries), pill counts and claims data, direct observation,
laboratory testing and monitoring by electronic technologies
[5] (eg, packaging devices, digital medicines, ie, ingestible
sensors), and video monitoring. Self-report and use of electronic
technologies are traditionally and more frequently reported
methods for measuring adherence in studies to improve
medication adherence, as they offer insight into
medication-taking behaviors useful for intervention [5,6].
Evidence suggests that electronic monitoring is better at
detecting poor adherence compared with self-report [7,8], which
often relies on recall. However, self-report is low cost and
relatively easy to implement [6]. An advantage of electronic
monitors is the ability to compile details about dosing history,
as electronic monitors provide the time and date the medications
were taken.
Currently used technologies that electronically compile dosing
histories to determine adherence include packaging devices,
digital medicines [9-11] (ie, ingestible sensors), and video
monitoring [12]. Electronic packaging devices of pill caps,
pillboxes, and blister packs differ by manufacturer, but they
broadly use sensors to detect state changes in devices, for
example, sensing cap or lid openings or closings, which indicate
that medication has been taken. These “taking” events are
associated with a date and time stamp to determine timing
adherence, and these events have evidence of reliability for
medication adherence both in clinical and research settings [13].
Although packaging devices can detect taking and timing
adherence, using them requires disruption of already established
medication-taking routines and organization systems, as users
must store their medications in these devices for tracking
[14,15]. Newer technologies, such as the ingestible sensor or
video monitoring, overcome limitations imposed by packaging
devices. The ingestible sensor allows users to keep their
established routines, but it requires users to wear an adhesive
patch attached to the abdomen to sense pill ingestion. The
comfort associated with wearing the patch produced mixed
reviews by patients [9]. In addition, ingestible sensors and video
monitoring are intrusive and may be more appropriate for
medications that require direct supervision to determine if
medication was actually taken [16,17].
Specific Objectives
Capitalizing on the ease of self-report measures, allowing for
end user flexibility with the methods already in use to manage
medications and capitalizing on the dosing history that can be
compiled through electronic technology, we investigated the
feasibility of patients using a smart button to self-track
medication adherence. The purpose of this study was to evaluate
the feasibility of using a novel approach to measure medication
adherence in a way that capitalizes on the ease of self-report
and the ability to electronically compile dosing histories by
having patients self-track medication taking using a smart
button. The smart button is a component of our mobile health
(mHealth) system that was field tested with the smart button in
this study. In addition to describing our mHealth system in this
paper, we (1) describe recruitment, enrollment and participant
characteristics, (2) report the number of times we successfully
set up the mHealth system in the clinic setting, (3) describe
participants’ willingness to use the mHealth system and
instances when they did not desire to use the system, and (4)
evaluate concordance between self-report data acquired using
the adherence self-tracking feature of our mHealth system
compared with an established packaging device.
Methods
Study Design
In preparation for future studies, we conducted this small
feasibility study in 3 phases over a 52-day period, with repeated
daily measurements of medication adherence. Phase 1 lasted
for 14 days, and it was designed to introduce participants to
using the smart button to self-track medication taking and
receiving standard short message service (SMS) text messages,
whereas phase 2 comprised 30 days of tailored SMS text
messages. Phase 3 lasted for 7 days, and participants again
received the standard SMS text message when the button was
pressed. As this was a feasibility study, the focus was on
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understanding whether the smart button technology could be
used by patients in their home environments. Our goal was to
obtain 260 data points while minimizing the participant burden
in the chance that the smart button technology did not work. As
a result, we consecutively enrolled 5 participants. Data were
collected between March 2018 and June 2018. Institutional
review board approval was obtained, and all participants
provided written informed consent before beginning the study.
Participants
Individuals aged 21 years of age or older, with a diagnosis of
chronic kidney disease (CKD) and who self-administered at
least one antihypertensive medication daily, were eligible for
study participation. In addition, individuals needed to be able
to speak, hear, and understand English, have the ability to open
pill bottle caps, and be willing to use study devices. If
participants were receiving dialysis at the time of screening,
they were excluded because of the burden of dialysis treatment.
Cognitive impairment was assessed, and only those with a score
of 4 or greater on the 6-item Metal Status Screen Derived from
the Mini-Mental Status Exam were included [18].
Setting
Participants were recruited from an ambulatory nephrology and
hypertension clinic within the Indiana University Health system
in Indianapolis, Indiana. Nephrologists prescreened patients
taking antihypertensive medications and referred them to the
research assistant (RA) for further screening.
Mobile Health System
The mHealth system capitalizes on Internet of Things
technologies to deliver real-time SMS text messages on the
basis of the time medications are taken and documented by the
smart button press. The main elements of the mHealth system
included a smart button and companion mobile app, a
cloud-based server with a computer algorithm containing text
messages, and an SMS text message platform (see Figure 1).
We selected the smart button linked to a smartphone as the
mHealth system, as we desired to develop an approach to
measure medication taking and timing adherence without
requiring users to store their medications in devices that were
different from what they already used. Each of the mHealth
system components is described below.
Figure 1. Components of the mobile health system. SMS: short message service.
Smart Button and Companion Mobile App
The first element of this system is a commercially available
smart button named the Stone (Pebblebee). The smart button is
a Bluetooth-enabled device that can be programmed using the
companion smartphone-based app called Pebblebee, hereafter
referred to as the app. The smart button can be easily
programmed to perform a variety of tasks, such as tracking
down a lost smartphone or using the smart button to control the
volume on one’s smartphone. The smart button is 0.9×0.8×0.5
inches in size, and it weighs 0.3 ounces. The battery life is listed
as 1 year, and the battery is replaceable (retrieved from website).
The smart button has a metal ring that allows it to be placed on
a key chain. The smart button is compatible with iOS 8.3 or
later and Android 5.0 or later, and it requires all phones to have
Bluetooth Low Energy 4.0 (retrieved from website). The
Bluetooth range is up to 150 feet, according to the
manufacturer’s product information. The smartphone app
interacts with the smart button. For example, when the smart
button is pressed, it sends a signal via the Bluetooth connection
to notify the app it was pressed. The app can be programmed
to react to button presses from the smart button to perform
shortcuts for tasks using a smartphone. For example, the app
can be programmed so that the smart button can be used to take
smartphone photos from a distance or to find a phone with the
push of a button. For our purposes, we programmed the app to
send an event to a cloud-based server we set up for this study
using a webhook. A webhook allows real-time transfer of
information to other apps running at remote locations.
Smartphones
Smartphones are probably the most well-known and ubiquitous
smart and connected devices. A total of 3 in 4 Americans own
a smartphone [19]. Smartphone capabilities such as SMS text
messaging, apps, and connecting other devices to them, make
smartphones potentially useful technologies to support
adherence [20]. The mHealth system and use of the smart button
rely on the use of a smartphone. Participants were offered study
smartphones to use during the study; however, all elected to
use their personal smartphones. The RA assisted participants
with device setup in the clinic, including downloading and
setting up the app and webhook.
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Cloud-Based Server With a Computer Algorithm to
Deliver Short Message Service Text Messages
The cloud-based server acted as an endpoint for receiving events
from the smart button app via the webhook. When the
cloud-based server received a notification from the app,
signaling that the smart button had been pressed, both the
participant and the timing of the event were used as input data
by the computer algorithm to deliver subsequent SMS text
messages. The computer algorithm comprised decision rules
that determined the type of text message to send to participants
via SMS. This association is made by the algorithm extracting
the unique ID from the event received by the server and by
looking up the participant who was assigned that smart button.
The server processed the events according to the algorithm in
Textbox 1.
Textbox 1. Algorithm through which the server processed events.
If the event was received, then the algorithm determined study phase and day of study (phase 1: study days 1-14; phase 2: study days 15-45; phase 3:
study days 46-52), and then subsequently the server sent an SMS text message to the participant, acknowledging they pressed the button correctly.
These decision rules can be expressed as phase 1 of study={Study days 1-15}
IF participant linked with unique ID={confirmation message that system received button press notification}
If the event was received during phase 2, then the server sent a tailored SMS text message from Table N depending on the study day.
ELSE IF participant time associated with goal time={positive reinforcement message sent}
Programmable Short Message Service Provider
To push SMS text messages to participants, we used the SMS
text platform provider Twilio, a platform as a service, which
facilitates sending SMS text messages to mobile phones on
behalf of an app. When the cloud-based server was ready to
send an SMS text message to a participant, a request was sent
to the SMS text platform, and an SMS text message was then
sent to the specified participant’s mobile phone number. The
SMS text platform responded with either a unique ID for the
request or an error message explaining why the request failed.
We assumed that receipt of a unique ID for the request implied
the participant eventually received the SMS text message on
the mobile phone.
Short Message Service Text Messages
In preparation for future intervention research, we designed 2
types of SMS text messages for this study: (1) standard and (2)
tailored, which were delivered in specific phases of the study.
Evidence from systematic reviews of medication adherence
interventions conducted across several chronic conditions shows
promise for interventions that use SMS text messaging [21-23].
The use of SMS text messaging delivered via smartphone has
been shown to improve medication adherence. A total of 2 recent
reviews, 1 integrative and 1 meta-analysis of randomized
controlled trials, suggest that use of SMS text messages improve
adherence across a variety of patient populations by
approximately 17% [21,24], and therefore incorporating SMS
text messages in mHealth-based interventions to improve health
behavior change interventions is warranted.
Standard Short Message Service Text Messages
Principles of interface design indicate that providing feedback
to users so they understand the technology is working is a best
practice of user-centered design [25]. Accordingly, the standard
text message stated “thank you for pressing the button” for
participants to know that their button press was recorded (ie,
the technology worked).
Tailored Short Message Service Text Messages
Tailored SMS text messages were developed on the basis of
systems thinking, which emphasizes habit formation using
reliable systems (eg, routines) embedded in personal
environments [26]. As systems thinking focuses on using
established and reliable systems to support medication taking,
it is an approach that moves away from “remembering.”
Evidence suggests that consistent medication-taking routines
support medication adherence [14], and aligning behavior with
individuals’ personal environments, habits, and routines can
support medication taking. Messages were tailored on the basis
of whether medications were taken “On Time” or whether
medications were taken “Outside Med Time.” Both types of
messages were designed to draw attention to the behaviors and
environments that were supporting taking medication, with the
“on time” messages designed to draw attention to the
environments and routines working to support taking medication
and the “outside med time” messages designed to encourage
thinking about processes and routines that could be changed to
support taking medications on time for the next scheduled dose.
SMS text feedback messages were developed to be delivered
in response to smart button presses. In phase 1 and phase 3,
standard SMS text messages read, “Thank you for pressing the
button” on the basis of user-centered design principles that
indicate users require a mechanism to determine if the
technology is working as intended [25]. During phase 2, tailored
SMS text messages were sent to participants on the basis of
medication timing. A total of 60 SMS text messages were
developed in total, with 30 “on time” messages designed to be
delivered if participants took medications within ±3 hours of
their regularly scheduled time, and 30 “outside goal time”
messages were designed to be delivered when participants took
their medications outside this dosing interval (ie, outside the
±3-hour dosing interval). Sample SMS text message content
and timing of delivery is shown in Figure 2.
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Figure 2. Sample short message service text messages sent across study phases.
We set the ±3-hour window as taking a drug within 25% of the
dosing interval maximizes drug bioavailability and effectiveness
[27]. The SMS text messages were designed to be delivered in
response to the smart button press, indicating the medication
was taken. If participants pressed the button more than once
daily during phase 2, the first message sent was the designated
tailored medication adherence feedback based on the timing of
the button press (described above), and subsequent presses on
the same day triggered the same standard message participants
received in phases 1 and 3.
Feasibility Measures
Recruitment and Enrollment
We tracked the number of patients seen in the clinic, screened
for the study, and enrolled. Reasons for not participating in the
study were tracked when provided.
Participant Characteristics
Demographics collected at study enrollment included gender,
race, ethnicity, education, marital and employment status, annual
income, CKD stage, and participant self-report of coexisting
medical conditions. Data were collected and entered into a
study-specific Research Electronic Data Capture (REDCap)
database [28].
Mobile Health Setup in Clinic
We tracked the number of times the mHealth set up. Setup
included the ability to download the companion app, set up the
webhook, press the smart button, as well as receipt of the test
SMS text message that indicated the system was operating as
intended.
Willingness to Use the System
In addition to the data tracked about participant recruitment and
enrollment, we tracked instances when participants did not
desire to use the mHealth system and reasons why. Dropouts
and technology problems reported by participants were noted
and summarized. These were identified during the scheduled
RA phone calls with participants.
Medication Adherence
We reported medication adherence (proportion of prescribed
doses taken on time) to describe adherence in this sample and
better interpret the results. To measure adherence, we used an
electronic medication-event monitor (EMM) pill cap that
measured adherence on the basis of the number of medication
bottle cap openings recorded, as measured by the Medication
Event Monitoring System TrackCap (MEMSCap, AARDEX
Group), expressed as a percentage. The MEMSCap contains a
microelectronic circuit in the cap that registers the date and time
when the cap is removed from the bottle of pills. These time
stamped events are stored and can be downloaded to the web
portal medAmigo [29] using a Universal Serial Bus–reader
device that transfers cap data to the platform. The medAmigo
is a secure cloud-based software platform, with access provided
to investigators with use of the MEMSCap. Medication
adherence was measured by EMM using the medication
adherence scores derived from the MEMSCap and that were
JMIR Form Res 2019 | vol. 3 | iss. 2 | e13558 | p.5http://formative.jmir.org/2019/2/e13558/
(page number not for citation purposes)
Bartlett Ellis et alJMIR FORMATIVE RESEARCH
XSL•FO
RenderX
calculated automatically by medAmigo on the basis of the
dosing history.
Concordance
There were 2 ways that concordance was measured. First, the
number of events in which the recorded smart button events
had a corresponding EMM event recorded on the same day was
used. Second, we evaluated the number of these concordant
events that occurred within ±5 min of one another and explored
the timing in which the smart button press was activated and
when the EMM device recorded a medication-taking event. The
MEMSCap device was selected for the reference comparison,
given its ability to measure timing adherence and evidence of
its ability to estimate medication adherence [13,30-32].
Acceptability
Acceptability was based on qualitative feedback provided by
participants. The RA documented comments made by study
participants at each of 3 points of contact. The RA had 3
scheduled phone calls with participants during the study in
which comments may have been documented, as well as during
any points of contact when troubleshooting the mHealth system
technologies may have occurred. The RA used a semistructured
interview guide for phone calls. Following phase 2, the RA
asked about participants’ thoughts on whether the SMS text
messages were helpful to support medication taking.
Procedure
At enrollment, all participants received study devices and
in-person training by the RA on how to use the study devices.
A unique ID was assigned to each button; therefore, our team
could identify which participant had each button when a button
was pressed. In addition, each participant received a unique
study number that was used to set up the mobile app. The RA
assisted participants with downloading and installing the app
on their mobile phone. The app was required to run in the
background of participants’ phones to detect smart button
presses. The RA instructed participants to ensure the Bluetooth
on their mobile device was turned on and the app was open
when pressing the smart button. Next, we sent an SMS text
message with information needed to configure the app to
communicate with the cloud server when the smart button was
pressed by the participant. This critical step allowed us to (1)
confirm we had the correct mobile phone number, as the cloud
server could send the participant the SMS text message, and it
allowed us to (2) remove potential errors caused by transcribing
setup information into the app. We could easily copy and paste
the setup information into the app directly from the received
SMS text message on the participant’s mobile phone. Before
leaving the clinic, participants demonstrated use of the smart
button, and each participant received a confirmation SMS text
message indicating proper setup. To thank participants for their
time in talking with the RA and using the study devices, they
received an honorarium of up to US $50 in gift cards. For the
purpose of this study, the RA selected 1 prescribed daily blood
pressure lowering medication from participants’ prescribed
medication list, and participants were instructed to keep this
medication in the MEMSCap bottle. The RA instructed
participants to take this medication as prescribed and press the
smart button when the medication was taken. The RA asked
participants to identify a date on which they would start using
the study devices, and this was recorded as the study start date.
In addition, the RA asked participants to identify the time when
they usually took the selected medication. The date and time
were recorded as the study start date, and the time was used to
calculate the dosing interval. Participants were instructed to
place their supply of antihypertensive medication inside the
MEMSCap bottle and begin taking it from the MEMSCap bottle
on the selected start date. All enrolled participants were
instructed by the RA on how to use the smart button to self-track
their daily medication taking. Each day, the participants were
to remove their selected medication from the MEMSCap bottle
at the designated time, then press the smart button. Telephone
calls were made by the RA at days 15, 46, and 52 to troubleshoot
technical problems, determine if participants received SMS text
messages, and provide instructions on returning devices to the
study team at study end.
Data Analysis
Study data were collected and stored using REDCap electronic
data capture tools, hosted at Indiana University [28]. Data were
analyzed with descriptive statistics appropriate for level of
measurement using IBM SPSS version 24.0 (IBM). Missing
data for the smart button and EMM were coded as a failure to
record data, with the exception of the days that participants
reported not using the devices, and concordance analysis was
adjusted appropriately. Frequency counts and percentages were
used to summarize recruitment and enrollment, participant
characteristics, the number of smart button press and MEMSCap
events recorded, and concordance. Graphs were used to examine
concordance between data acquired from self-tracking of
medication adherence using the smart button and medication
adherence recorded with the MEMSCap. Narrative analysis of
comments made by participants was used to identify strengths
and opportunities to improve the study for the future clinical
trial.
Results
Overview
A total of 19 patients were prescreened for study eligibility in
the clinic by physicians. Of these, 6 did not meet study eligibility
criteria. Reasons for exclusion included the following: CKD
stage >4 (n=3), no diagnosis of CKD (n=1), inability to
self-manage medications (n=1), and not prescribed an
antihypertensive (n=1). A total of 4 (21%) patients meeting
prescreening criteria declined to participate. A total of 3 out of
4 patients provided reasons for their lack of interest in study
participation. A total of 1 candidate used a flip phone, and the
participant was not willing to carry another phone. The other 2
candidates were recruited for another study on day of clinic,
and they were not willing to stay for recruitment discussion. Of
the 3 remaining patients approached for further screening by
the RA, 2 participants were willing to participate, but they were
unable to stay in the clinic to obtain the study devices and be
trained on setup, as they were dependent on prearranged
transportation services. Of the 6 patients screened by the RA,
1 patient did not meet inclusion criteria, and the patient was
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excluded, as this individual was not willing to use a smartphone.
A total of 5 patients were enrolled in the study, 2 participants
(40%) were women, and 3 participants (60%) were men. The
mean age was 52.6 years (SD 22.49; range: 20-70). Table 1 lists
the self-identified health conditions of the 5 participants; 4
participants (80%) had more than 3 conditions and 2 participants
(40%) had 4 or more. The 5 participants took a mean total
number of 8.6 (SD 5.02) medications (range: 3-14 medications),
and out of those, a mean of 2.8 (SD 1.64) were antihypertensive
medications.
Feasibility of Mobile Health System Technology Setup
in the Clinic
The RA was successful in assisting all 5 participants (100%)
with downloading the smart button app on their respective
smartphones, setting up the webhook actions in the app, and
testing the smart button device in the clinic setting. All 5
participants were able to press the smart button, and each
participant received the test SMS text message while in the
clinic setting, demonstrating the system was set up and operating
correctly.
Technology Challenges
A total of 2 participants reported technology problems during
the study. Troubleshooting included ensuring the phone app
was open and Bluetooth was turned on, as well as confirmation
that the smart button was pressed when taking pills. Although
each participant gave confirmation, messages were still not
received by these 2 participants. A total of 1 participant texted
the RA study phone to troubleshoot, as SMS text messages were
not received, but the phone number the participant texted from
did not match the phone number provided by the participant at
study enrollment. The participant validated that only 1 mobile
number was used for both voice and SMS text messages. This
problem remained unresolved.
Device Events Recorded Over Study Period
All 5 participants initiated the use of the EMM on the start day
they indicated. Over the course of the 52-day study, with 5
participants, we expected to yield 260 data points (5
participants×52 days) per smart button and MEMSCap device.
Over this monitored period, 36.5% (n=95) of the expected events
were recorded with the smart button, and 76.2% of the expected
events (n=198) were recorded with MEMSCap. There was 1
participant for whom no smart button events were recorded,
although the system worked when tested in the clinic setting
during enrollment.
Measurement Concordance
Concordance between events recorded on both devices (n=94)
was achieved on an average of 47.4% (range 0%-81.3%) of the
time. Event recordings and concordance for each participant
across the study period in which participants reported using the
devices are shown in Figure 3. Among the concordant events,
on average, 58.5% of the events occurred within ±5 min of one
another.
We also examined these concordant events to determine which
event was recorded first or if the timing of the device activation
occurred at the same time. There were 34 events in which the
time recorded for the smart button preceded the MEMSCap
time, indicating the smart button was pressed before removing
medication from the bottle. The mean difference in time between
these 2 event recordings was 55 min (median 8 min; minimum:
1 min, maximum: 17 hours 6 min). In contrast, 45 events were
recorded first on the MEMSCap device, with a mean time
difference of 29 min (median 1 min, minimum: 1 min,
maximum: 9 hours 22 min). In 15 cases, the smart button time
recorded was identical to that of the MEMSCap, indicating the
button was pressed at the same time medication was removed
from the MEMSCap bottle. A total of 1 participant noted that
during the course of the study, a pill had been removed from
the MEMSCap bottle and taken, but the participant received a
phone call, and then, the participant did not press the smart
button until remembering to do so at a later time. A total of 1
participant ended use of the study devices on day 48 because
of travel and desire not to travel with the study devices. A total
of 3 participants used the devices for longer than the 52-day
study period. Feasibility and Acceptability of Text Messages
Of the SMS text messages delivered, correct messages in the
algorithm were sent 100% of the time. However, in 1 case, a
participant traveled to another time zone, and the algorithm
responded on the basis of the server time zone. Owing to the
time zone difference, the medication taking was outside the
goal time of the server time zone, and, as a result, the algorithm
sent the appropriate feedback message, but this did not match
the participant’s behavior on the basis of the new time zone.
Overall, participants thought the idea of sending messages about
taking medications via SMS text messages was a good idea;
however, the participants shared different ideas about the timing
and content of messages, as reflected in their comments below.
Of the 3 participants that received the tailored SMS text
messages, 2 of them found them helpful. One participant who
was highly adherent to taking medications commented, “I did
not find the messages helpful.” This participant suggested
sending messages “when medications are taken late” (ie, outside
the dosing interval) instead of sending messages when people
are adherent . Another participant indicated the messages were
all helpful but suggested to “send messages every couple of
days.” This participant felt, “it was good to get encouragement
when the messages came.” This same participant also indicated
that the participant forgot to press the button a couple of days.
Similarly, another participant noted, “I felt messages were
encouraging and helpful to know I was taking my meds
[ications] on track.” This participant stated that “the daily
messages are helpful in motivating continued habits,” and the
participant further stated that there was not “any one message
that was not helpful.” Similar to the first participant comment,
this participant also thought that sending a message to “prompt
people who are usually late or way off” in taking medication
might be helpful. The 1 participant who did not receive messages
during the study commented about the helpfulness of receiving
messages and indicated that “simple messages to remind to take
meds would have been helpful with a timeline of when to take
the medicine.”
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Table 1. Participant characteristics.
CountCategory
Gender
3Male
2Female
Race
4White
1American Indian or Alaska Native
Ethnicity
2Hispanic/Latino
2Not Hispanic/Latino
1Unknown
Education level
2High school graduate
1Some college/no degree
1Bachelor’s degree
1Doctoral degree
Marital status
2Never married
1Married
1Separated
1Widowed
Employment status
2Full time
2Retired
1Not employed
Annual income
1US $20,000-$30,000
2US $40,000-$50,000
1>US $100,000
1Prefer not to disclose
Chronic kidney disease stage
1Stage 2
1Stage 3A
2Stage 3B
1Stage 4
Subject-identified medical conditions
5High blood pressure
3Heart disease
2Arthritis
2Asthma
1Back pain
1Chronic obstructive pulmonary disease
1Diabetes
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CountCategory
1Emphysema
1Stroke
1Congenital disorder
Figure 3. Concordance between smart button self-tracking and electronic monitoring of medication adherence. Gray boxes indicate event recorded on
the device; white boxes indicate no event recorded. Type of Smartphone Operating Platform: 1Android, 2iOS; Wavy lines: participant travel, Dotted
lines: refusal to use the device. Concordance determined by days participants reported using one or more of study devices. MEMS: Medication Event
Monitoring.
Table 2. Medication adherence acquired by electronic caps for each participant and study phase.
Phase 3 adherence (Day 46-52),
(%)
Phase 2 adherence (Day 15-45),
(%)
Phase 1 adherence (Day 1-14),
(%)
Overall adherence (Day 1-52),
(%)
Participant
1009710098A
1465722B
1009710098C
1009110095D
100878688E
Medication Adherence
The average medication adherence score across the study time
frame was 80.2% (range 22%-98%) when recorded using EMM.
Individual participant adherence scores are shown in Table 2.
Discussion
Principal Findings
Existing technologies used to measure medication adherence
provide data about timing and taking adherence, but they can
be disruptive and intrusive in patients’ routines. This article
focused on evaluating the feasibility of using a smart button to
self-track medication adherence as part of an mHealth system
to deliver subsequent SMS text messages on the basis of
medication adherence timing. We examined the feasibility of
recruiting and setting up this mHealth system in the clinic setting
on participants’ own phones, patients’ willingness to use the
self-tracker technology, and concordance between data acquired
from the smart button and an established electronic packaging
device. The main findings of this feasibility study are the lessons
learned about the selected smart button and our mHealth system,
which will serve to guide future studies.
Lessons Learned and Recommendations for Future
Study
We demonstrated that it is feasible to recruit participants and
set up the technology in the clinic setting, which we did for the
5 individuals participating in this study. However, our study
procedures that included recruiting, enrolling, and setting up
technology in the same clinic appointment may have deterred
some individuals from participating because of the added time
to their clinic appointment. We chose this approach as a
pragmatic one, but for 2 people, this approach interfered with
previous transportation arrangements and precluded them from
participating. Future studies should ensure study procedures are
flexible to meet patient needs and maximize participation, and
letting patients know in advance about potential research
opportunities may be beneficial. There are benefits and
challenges to participants using their own smartphones. All 5
of our participants chose to use their own phones. This was
helpful at the outset, as they were familiar with the functionality
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of the phone. However, as Ling [33] points out, having
expectations that mobile phones all provide the same level of
access and functionality in designing and delivering mHealth
interventions is often taken for granted. While troubleshooting
technological problems, our team discovered that individual
privacy settings were interfering with delivery of messages. A
total of 2 iPhone users had a setting that if the SMS text message
sender was unknown, the messages would be automatically
deleted. On the basis of this finding, we recommend that in
future research, phone numbers associated with the study be
added to participant phone contact lists at study outset so that
participants receive study messages and phone calls. One of the
greatest challenges we encountered in our study was that the
smart button only worked when the companion app was running
in the background on the phone. Despite knowing this in
advance and teaching our participants to keep the app open,
there is a high likelihood that the app was closed, and it is the
reason why smart button presses were not received. Smart button
use for self-tracking medication adherence would be more useful
if participants did not need to worry about the companion app.
Moving forward with future research, we recommend exploring
if other smart buttons on the market can operate without
requiring the user to take this extra step or designing new
systems that overcome this obstacle. We also learned that time
zone changes posed challenges for our mHealth system, and
time zone changes posed challenges for measuring medication
adherence. As the determination of medication adherence is
based on date and time, travel to other time zones can interfere
with a regular schedule of medication taking. The smart button
is connected to the phone, so the time zone of the user is the
appropriate time zone, but if the server uses the time zone to
send message algorithms, such as the one our team designed,
then the messages may not appropriately match the
medication-taking behavior. We found a study reported in the
literature that encountered a similar difficulty with mHealth
technology and medication adherence, and those researchers
changed the programming code to ensure medication time was
based on the mobile phone users’ local time rather than the
server or research teams’ time zone [34]. We believe this a
potential problem for all types of electronic measures of
adherence, especially if the measurement device does not have
the capability of sensing and responding to geographical
changes. For example, the EMM MEMSCap device we used
does not sense time zone changes autonomously; therefore, this
is something that users would need to report to investigators to
more accurately measure adherence if participants travel while
having their medication taking monitored. On the basis of these
findings, future investigations should ensure the programming
of the mHealth system can respond appropriately to time zone
changes. Investigators may wish to have patients keep a log of
any time zone changes that occur during the course of their
medication monitoring in medication adherence studies,
including in studies using existing electronic medication
monitoring devices. We also learned that the technology may
not work outside of the United States; therefore, this is an
important consideration for planning future research. Future
research should explore the ideal conditions under which the
smart button has utility both from a measurement and
intervention perspective. In future research, there is a need to
consider individual user characteristics, including gender, race,
ethnicity, income, number and types of medications taken, and
different chronic conditions, to determine if using a smart button
self-tracker and mHealth system is feasible and then
subsequently determine if using a smart button self-tracker and
mHealth system can improve medication adherence. Future
research will also need to further evaluate the content of tailored
SMS text messages for content and face validity congruent with
systems thinking and determine the best timing for delivering
messages. Engaging patients in the participatory codesign of
these messages may be a salient opportunity and best practice
approach to engage the target end user [35,36].
Limitations
This is a small feasibility study focused on evaluating the
technology components of the mHealth system and the ability
to use a smart button to self-track medication adherence in the
field. The sample size is small, but it was purposefully chosen
to test feasibility of the smart button and mHealth system to
operate according to plan in the patient home environment.
Although the sample size limits generalizability, the study was
useful in identifying opportunities to improve future iterations
of the mHealth system components. Although we assessed
medication adherence using an EMM bottle device and asked
about self-reported adherence to devices, we do not have
baseline medication adherence data for participants.
Self-reported adherence, although likely to overestimate
adherence, should be evaluated in future studies at baseline.
Another limitation was that we relied on the SMS text message
data to determine if the smart button was pressed. Participants
reported pressing the button, yet no events were received on the
server, and therefore no SMS messages were generated. Whether
or not the participants pressed the button was not objectively
evaluated in the study procedures; therefore, we do not have
data on whether participants actually pressed the button. One
of the challenges in medication adherence research is that there
is no gold standard measure of adherence. The wide variability
in measurement methods and ways of acquiring information on
medication taking (self-report, indirect, and direct) are
challenges in conducting this research. The smart button
provided a self-report measure of medication taking, and we
used the EMM bottle device to provide an indirect objective
measure of adherence. We recognize that both of these methods
come with limitations, which is why we used the concordance
measure to make comparisons, but nonetheless, without direct
observation, both of these approaches provide only an estimate
of adherence. As the smart button is a self-report measurement
approach, it is limited to patients’ willingness to actually report
their medication taking. However, our smart button approach
is an innovative way to self-report medication adherence, as it
allows for real-time self-report of medication adherence and
does not rely on recalling if medications were taken, which is
the basis for most self-report measures of adherence [6]. Among
self-report measures that rely on recall, adherence is often
overestimated by approximately 30% [37]. The smart button
component of our mHealth system provides a novel self-report
approach to measuring medication adherence, as it provides
time and date data that are lacking from other common
self-report methods for measuring adherence.
JMIR Form Res 2019 | vol. 3 | iss. 2 | e13558 | p.10http://formative.jmir.org/2019/2/e13558/
(page number not for citation purposes)
Bartlett Ellis et alJMIR FORMATIVE RESEARCH
XSL•FO
RenderX
Conclusions
We demonstrated that it is feasible for participants recruited
from the clinic setting to use a smart button device to self-track
medication taking, although the selected device may not reliably
work across smartphone operating systems and in participant
home environments. Adherence was relatively high in this
sample, although corresponding smart button presses were not
consistently recorded, demonstrating poor concordance. We
believe the discrepancy lies in the selected smart button
technology and not in the ability of patients to self-track their
medication taking, although this requires further study. Although
there are some limitations to the use of the specific smart button
used in this study, we were able to identify opportunities to
improve the system to support testing in future studies.
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